Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

The company and other insurers have faced backlash from patients who say they were denied necessary care and providers say ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

and UnitedHealth's OptumRx. It concludes that the PBMs generated $7.3 billion by marking up drugs in these categories over their estimated acquisition costs between 2017 and 2022, in some cases by ...

It's easier and faster and you'll avoid the hassle of trying to cancel auto-renew. My experience with Optum RX has been terrific until today. I noticed they had charged my HSA card twice for a ...

The final text saw a number of legislative proposals culled in order to get it over the line, including measures that would have introduced stricter controls over the PBM sector that had been ...

New York, New York--(Newsfile Corp. - May 1, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced the effective date of its 1-for-7.97 share ...

The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for ...